吉利德科學公司
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionAirain ltd
Latest Disclosed Ownership95,919 shares
Latest Disclosed Value $ 6,789,000
Airain ltd reports 76.15% decrease in ownership of GILD / Gilead Sciences, Inc.

On August 8, 2017 - Airain ltd filed a 13F-HR form disclosing ownership of 95,919 shares of Gilead Sciences, Inc. (US:GILD) valued at $6,789,147 USD as of June 30, 2017. The entity filed a previous 13F-HR on May 9, 2017 disclosing 402,196 shares of Gilead Sciences, Inc.. This represents a change in shares of -76.15% during the quarter. The current value of the position is $12,388,898 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2017-08-08 2017-06-30 13F Gilead Sciences Com 375558103 95,919 -306,277 -76.15 6,789 -75.15 0.3004
2017-05-09 2017-03-31 13F Gilead Sciences Com 375558103 402,196 110,923 38.08 27,317 30.97 1.3358
2017-02-10 2016-12-31 13F Gilead Sciences Com 375558103 291,273 156,548 116.20 20,858 95.68 1.6806
2016-11-08 2016-09-30 13F Gilead Sciences Com 375558103 134,725 -170,677 -55.89 10,659 -58.16 0.6319
2016-08-05 2016-06-30 13F Gilead Sciences Com 375558103 305,402 113,472 59.12 25,477 44.50 1.4728
2016-05-09 2016-03-31 13F Gilead Sciences Com 375558103 191,930 36,009 23.09 17,631 11.74 1.2198
2016-02-11 2015-12-31 13F Gilead Sciences Com 375558103 155,921 44,970 40.53 15,778 44.83 1.0845
2015-11-09 2015-09-30 13F Gilead Sciences Com 375558103 110,951 -18,188 -14.08 10,894 -27.95 0.6524
2015-08-05 2015-06-30 13F Gilead Sciences Com 375558103 129,139 27,444 26.99 15,120 51.52 0.8488
2015-05-11 2015-03-31 13F Gilead Sciences Com 375558103 101,695 15,808 18.41 9,979 23.26 0.6100
2015-02-12 2014-12-31 13F Gilead Sciences Com 375558103 85,887 -11,952 -12.22 8,096 -22.27 0.6630
2014-11-07 2014-09-30 13F Gilead Sciences Com 375558103 97,839 21,153 27.58 10,415 63.81 0.7069
2014-08-05 2014-06-30 13F Gilead Sciences Com 375558103 76,686 76,686 6,358 0.5209
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.